A Phase I, Single-Center, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD7268 When Given in Multiple Ascending Oral Doses in Healthy Subjects

Trial Profile

A Phase I, Single-Center, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD7268 When Given in Multiple Ascending Oral Doses in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs AZD 7268 (Primary)
  • Indications Anxiety disorders; Depressive disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Sep 2009 Planned end date changed from 1 Aug 2009 to 1 Oct 2009 as reported by ClinicalTrials.gov.
    • 11 Sep 2009 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top